USE OF INTERFERON BETA FOR THE TREATMENT OF ALOPECIA AREATA

摘要

The present invention relates to a medicament for the treatment of alopecia areata. Interferon beta of the present invention may be administered to the subject suffering from said disorder topically (e.g. intradermally) or systemically. The present invention further encompasses compositions comprising interferon beta for use as a medicament in the treatment of alopecia areata. Said compositions may comprise other active agents, such as statins. In a preferred embodiment, interferon beta-lb is administered intradermally once a week for 4 to 6 weeks at a dose level of 4.5 to 30 microgram per 10 cm2 treated area.